JP Patent

JP2013525501A — 医薬組成物およびその製造方法

Assigned to Glaxo Wellcome Manufacturing Pte Ltd · Expires 2013-06-20 · 13y expired

What this patent protects

約１０ｍｇ／ｍＬのパゾパニブおよび約２〜約１３％ｗ／ｗの修飾シクロデキストリンを含む医薬組成物、ならびにその製造方法を開示する。

USPTO Abstract

約１０ｍｇ／ｍＬのパゾパニブおよび約２〜約１３％ｗ／ｗの修飾シクロデキストリンを含む医薬組成物、ならびにその製造方法を開示する。

Drugs covered by this patent

Patent Metadata

Patent number
JP2013525501A
Jurisdiction
JP
Classification
—
Expires
2013-06-20
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Wellcome Manufacturing Pte Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.